Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Dec 1;42(12):1067-1072.
doi: 10.1097/INF.0000000000004104. Epub 2023 Sep 26.

Open-labeled Randomized Controlled Trial on Efficacy of Azithromycin Versus Doxycycline in Pediatric Scrub Typhus

Anjali Sharma  1 , Vidushi Mahajan  1 , Vishal Guglani  1 , Nidhi Singla  1 , Shiv Sajan Saini  2
Affiliations
Randomized Controlled Trial

Open-labeled Randomized Controlled Trial on Efficacy of Azithromycin Versus Doxycycline in Pediatric Scrub Typhus

Anjali Sharma et al. Pediatr Infect Dis J. .

Abstract

Background: Doxycycline (DX) is the first-line therapeutic agent for scrub typhus. Macrolides, especially azithromycin (AZ), have been found to be equally efficacious as DX for treating scrub typhus in adults. We conducted this study to compare the efficacy of AZ versus DX in pediatric scrub typhus.

Study design: Open-label randomized controlled trial.

Methods: Children 1-14 years of age suffering from acute febrile illness of ≥5 days and with a positive scrub IgM serology were randomized to receive either DX (2.2 mg/kg/dose twice daily in <40 kg; 100 mg BD in >40 kg for 7 days) or AZ (10 mg/kg/day for 5 days). The primary outcome was defervescence within 7 days of DX or 5 days of AZ.

Results: We had 75 children randomized and analyzed using an intention-to-treat approach and 60 children analyzed via per-protocol analysis. The proportion of children achieving defervescence was comparable in 2 groups [per-protocol analysis: 90.9% in the DX group vs. 96.3% in the AZ group, RR: 0.94 (95% CI: 0.83-1.08)]. On Kaplan-Meier curves, AZ showed a significantly higher probability of defervescence at any time point during treatment as compared with DX (log-rank test P value 0.035).

Conclusion: AZ and DX had comparable rates of defervescence among children with scrub typhus. Trial registration No.: CTRI/2020/01/022991.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding or conflicts of interest to disclose.

References

    1. Taylor AJ, Paris DH, Newton PN. A systematic review of mortality from untreated scrub typhus ( Orientia tsutsugamushi ). PLoS NeglTrop Dis. 2015;9:e0003971.
    1. Kelly DJ, Fuerst PA, Richards AL. The historical case for and the future study of antibiotic-resistant scrub typhus. Trop Med Infect Dis. 2017;2:63.
    1. Rathi N, Kulkarni A, Yewale V; For Indian Academy of Pediatrics Guidelines on Rickettsial Diseases in Children Committee. IAP guidelines on rickettsial disease in children. Indian Pediatr. 2017;54:223–229.
    1. Sloan B, Scheinfeld N. The use and safety of doxycycline and other second generation tetracyclines. Expert Opin Drug Saf. 2008;7:571–577.
    1. Wallman IS, Hilton HB. Teeth pigmented by tetracycline. Lancet. 1962;1:827–829.

Publication types

LinkOut - more resources